TY - JOUR AU - Zhang, Shuyao AU - Liao, Wei AU - Wu, Qinshui AU - Huang, Xiaoshan AU - Pan, Zhen AU - Chen, Wang AU - Gu, Shuyi AU - Huang, Zuojun AU - Wang, Yiwen AU - Tang, Xu AU - Liang, Shanshan AU - Zhang, Xiaoyan AU - Chen, Yun AU - Chen, Shuang AU - Chen, Wanying AU - Jiang, Yi AU - Chen, Chen AU - Qiu, Guodong PY - 2020 DA - 2020/11/26 TI - LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2 JO - Cancer Cell International SP - 569 VL - 20 IS - 1 AB - Expression of the long non-coding mRNA LINC00152 has been reported to correlate with cancer cell resistance to oxaliplatin (L-OHP). However, little is known regarding the molecular mechanism of LINC00152 in esophageal cancer (EC). Hence, we intended to characterize the role of LINC00152 in EC, with a special focus on epithelial-mesenchymal transition (EMT) and L-OHP resistance. SN - 1475-2867 UR - https://doi.org/10.1186/s12935-020-01620-1 DO - 10.1186/s12935-020-01620-1 ID - Zhang2020 ER -